본문 바로가기

분류 전체보기

 (819)
Lennox-Gastaut Syndrome (LGS) Market Size and Share Analysis Lennox-Gastaut Syndrome (LGS) is considered as an epileptic encephalopathy and is defined by a triplet of multiple drug-resistant seizure types, a specific EEG configuration presenting bursts of slow spike-wave complexes or generalized paroxysmal fast activity, and intellectual disability. According to the National Institute of Health, LGS is a form of severe epilepsy that originates in childhoo..
Osteosarcoma Therapeutics Market Trends Analysis As per DelveInsight’s analysis, the Osteosarcoma therapeutic market in the 7MM was estimated to be USD 72.50 million in 2017 and is further expected to increase modestly in the forecast period 2020-30. Several clinical trials are ongoing in the Osteosarcoma market. The companies in the Osteosarcoma market are primarily focusing on tackling the issues of drug-resistance, which is the major reason..
Osteosarcoma Treatment Market Size and Share Analysis Osteosarcomas are rare, yet are the leading cause of deaths due to cancer in the pediatric population. It is a high-grade malignancy of mesenchymal origins. They are the most frequent forms of primary bone tumors and account for approximately 20% of all the bone tumors. With the incident population of less than 2500 in the 7MM (the US, EU5 (the UK, Germany, France, Italy, and Spain), and Japan)i..
Biliary Atresia Market Trends and Share Analysis In 2017, the total incident cases of Biliary Atresia in 7MM was 613. The incident cases in the United Kingdom and France were found to be 45 and 42 respectively (in 2017). The market size of Biliary Atresia in 7MM in 2017 was USD 2.9 million, which is expected to increase further during the forecast period 2017-2030. The key companies in the Biliary Atresia market include Albireo, Intercept Phar..
Medical Marijuana Research Updates Over the years the clinical research and trials conducted around marijuana have produced many noteworthy results and researchers have found them as a very significant treatment option. Worldwide numerous clinical trials are going to evaluate the safety, and effectiveness of medical marijuana for a number of diseases such as ChronicPain, Cachexia, Epilepsy, multiple sclerosis, Anxiety, and many o..
Glioblastoma Multiforme Market Growth Analysis As per the DelveInsight's estimate the Glioblastoma Multiforme market is anticipated to veer forward with a CAGR of 8.25% in the 7MM (i.e. the United States, EU5 (the UK, Germany, Spain, Italy, and France) and Japan). Some of the key companies, such as Bristol Myers Squibb, VBL Therapeutics, DelMar Pharmaceuticals, VBI Vaccines, Diffusion Pharmaceuticals, Ziopharma, Apogenix, DNAtrix, Immunomic ..
Glioblastoma Multiforme Treatment Market Trends Analysis Glioblastoma Multiforme are rare tumors with a global incidence of less than 10 per 100,000 people. As per the Delveinsight analysis, the total Glioblastoma multiforme incident population in the 7MM (i.e. the United States, EU5 (the United Kingdom, Germany, Italy, Spain, and France) and Japan) was estimated to be around 2900 in 2017, which is expected to further increase during the forecast peri..
Peripheral Nerve Injury Market Growth Analysis Every year, around 1.35 million people die due to vehicular or road accidents. Road crashes are also the most common cause of peripheral nerve injury (PNI), affecting the brachial BP or the radial, fibular, or sciatic nerves, typically in young motorcycle riders. The Peripheral Nerve Injury incidence in 2017 in the 7MM (i.e. The United States, EU5 (the United Kingdom, Spain, Germany, Italy, and ..

티스토리툴바